Dementia Prescribing Snapshot Cannot Establish the Safety of Its Small Benzodiazepine Subgroup

A low prescribing proportion is different from evidence that the medicine caused little harm.

What the supplied source reports

The retrospective cross-sectional study reviewed 139 older patients with dementia at a tertiary center. About five percent had benzodiazepine prescribing, most often lorazepam within that small subgroup. Antipsychotic and antidepressant prescribing was more common.

Limits and uncertainty

The single-center records had diagnostic-documentation limitations. The small benzodiazepine denominator limits conclusions about drug preferences, and the study did not provide a controlled assessment of benefit or adverse outcomes. Prescribing prevalence does not establish actual administration.

Implications for forensic review

For reviewing dementia care, obtain indication, dose, timing and observed behavior instead of inferring appropriateness from local frequency. Percentages within the benzodiazepine subgroup differ from percentages of the whole cohort. This study describes practice rather than proving treatment efficacy, low risk or causation of cognitive decline.

Source and related reading

Source reviewed: The Prevalence of Atypical Antipsychotics Antidepressants and Benzodiazepines Use in Dementia Patien (PMC9673055). Forensic applications above are interpretive analysis of the supplied publication.